Wells Fargo & Company MN Purchases 15,609 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Wells Fargo & Company MN lifted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 9.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 180,391 shares of the company's stock after purchasing an additional 15,609 shares during the period. Wells Fargo & Company MN owned approximately 0.11% of Option Care Health worth $4,185,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Barclays PLC lifted its stake in Option Care Health by 180.1% during the third quarter. Barclays PLC now owns 310,194 shares of the company's stock valued at $9,708,000 after buying an additional 199,454 shares in the last quarter. Central Pacific Bank Trust Division lifted its position in shares of Option Care Health by 6.9% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company's stock valued at $234,000 after acquiring an additional 650 shares in the last quarter. Nordea Investment Management AB boosted its stake in Option Care Health by 6.0% in the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company's stock worth $2,165,000 after purchasing an additional 5,365 shares during the period. Harbor Capital Advisors Inc. grew its position in Option Care Health by 2.7% during the 4th quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company's stock worth $4,945,000 after purchasing an additional 5,595 shares in the last quarter. Finally, Graypoint LLC purchased a new position in Option Care Health during the 4th quarter worth approximately $1,161,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Up 2.2 %

Shares of OPCH traded up $0.72 during mid-day trading on Friday, hitting $32.90. 1,560,649 shares of the company's stock were exchanged, compared to its average volume of 1,776,791. The stock has a market cap of $5.40 billion, a price-to-earnings ratio of 27.65, a P/E/G ratio of 2.30 and a beta of 1.07. The firm has a fifty day moving average of $33.36 and a two-hundred day moving average of $28.76. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Analysts Set New Price Targets

OPCH has been the subject of a number of research reports. Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Monday, April 21st. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and raised their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $33.75.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.